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ABSTRACT

A PILOT STUDY TO EXAMINE A THEREAPEUTIC EXERCISE
INTERVENTION ON FIBROMYALGIA SYMPTOMS

Mara H. Nelson
Department of Exercise Sciences
Master of Science

Objective. To examine the feasibility of a home-based, video therapeutic exercise
program on pain, fatigue, self-efficacy, and health status in fibromyalgia patients.
Methods. Nine individuals who were previously diagnosed with fibromyalgia completed
the study (out of an initial pool of 31). Subjects were randomly assigned to one of two
groups: a group who received a home-based therapeutic exercise video and a control
group who continued to undergo their current standard of care or “treatment-as-usual.”
The video group was instructed to conduct the exercises as prescribed in the 42-minute
video at least 3 times per week for 4 weeks. The treatment-as-usual control group was
instructed to continue to undergo their current standard-of-care and to not begin any new
treatments during that time. Instruments measuring self-efficacy, pain, fatigue, self-rated
health status and health distress were administered at baseline and 4 weeks.

Results. None of the variables analyzed showed a significant change between the
treatment and control groups over the course of the 4-week study.
Conclusion. This study was not sufficiently powered to detect differences between the
two groups. However, several of the treatment group participants subjectively indicated
that they found the exercises to be helpful in the management of their fibromyalgia
symptoms and the program did not exacerbate any of their symptoms. With this
information, it appears that patients are able to tolerate the treatment and are able to
complete the outcome measures. Between-group clinical outcomes will now need to be
assessed in a larger clinical trial.
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ABSTRACT
Objective. To examine the feasibility of a home-based, video therapeutic exercise
program on pain, fatigue, self-efficacy, and health status in fibromyalgia patients.
Methods. Nine individuals who were previously diagnosed with fibromyalgia completed
the study (out of an initial pool of 31). Subjects were randomly assigned to one of two
groups: a group who received a home-based therapeutic exercise video and a control
group who continued to undergo their current standard of care or “treatment-as-usual.”
The video group was instructed to conduct the exercises as prescribed in the 42-minute
video at least 3 times per week for 4 weeks. The treatment-as-usual control group was
instructed to continue to undergo their current standard-of-care and to not begin any new
treatments during that time. Instruments measuring self-efficacy, pain, fatigue, self-rated
health status and health distress were administered at baseline and 4 weeks.
Results. None of the variables analyzed showed a significant change between the
treatment and control groups over the course of the 4-week study.
Conclusion. This study was not sufficiently powered to detect differences between the
two groups. However, several of the treatment group participants subjectively indicated
that they found the exercises to be helpful in the management of their fibromyalgia
symptoms and the program did not exacerbate any of their symptoms. With this
information, it appears that patients are able to tolerate the treatment and are able to
complete the outcome measures. Between-group clinical outcomes will now need to be
assessed in a larger clinical trial.
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INTRODUCTION
Fibromyalgia Syndrome (FMS) is a perplexing condition that affects approximately 3.7
million people in the United States (1). Although it is a condition that most commonly
affects women, men and children have also been diagnosed. Prevalence has been
estimated at 3.4% for women and 0.5% for men (1, 2). The main criteria for diagnosis
include widespread pain and tenderness that must be experienced for at least three
months along with the presence of at least 11 of 18 pre-determined tender points (3).
Figure 1 illustrates the tender point areas that are commonly used for diagnosis.
Due to the uncertain etiology and the comorbid conditions associated with
fibromyalgia, one specific standardized protocol for treatment has not yet been
determined (4, 5). Successful treatment for FMS usually includes combinations of
various pharmacologic and non-pharmacologic interventions (5, 6).
The concept that physical exercise is beneficial is common knowledge regarding
many chronic diseases and conditions (7) and exercise has also been found to have
beneficial effects with regards to fibromyalgia (5, 8-12). However, proper exercise
prescription (13-15),and maintenance (16) is complicated. Although many modes,
durations and intensities of exercise have been examined with FMS, it has not been
determined whether one mode of exercise is significantly more beneficial than others (8).
Many research studies have focused on examining aerobic exercise programs and
fibromyalgia symptoms(8). However, when compared to sedentary counterparts,
individuals with FMS have lower levels of physical functioning (17) and lower peak
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activity levels (18) than their healthy counterparts and this can lead to exacerbation of
FMS symptoms upon the initiation of a standard aerobic exercise program (13).
Therefore, it appears as though less intensive exercise programs may result in
greater initial compliance and it is often recommended that FMS patients begin with a
light stretching program (13, 14, 19). Originally, flexibility/stretching programs were
primarily used as control groups in FMS research studies (20, 21). However, additional
research has focused on the benefits of flexibility/stretching programs on their own to
assist in improving FMS symptoms (22-25).
Additional research is needed on initial low-intensity exercise programs that
lessen the chance of symptom exacerbation and increase long-term exercise adherence
(11, 14). To date, a home-based, video, therapeutic exercise program developed for
individuals with FMS has not been studied. In order to determine if this program has
therapeutic value, a large randomized clinical trial is required. The first step to complete
this study is to determine its feasibility. Therefore, this pilot study evaluated the
feasibility of the exercise intervention. This intervention was comprised of a 42-minute
video that demonstrated stretches, therapeutic exercises, and light self massage
techniques that are designed to facilitate reduction in fibromyalgia symptoms, as well as
improve flexibility, enhance self-efficacy, and promote relaxation. The feasibility of the
outcome measures and the extent to which participants would comply with the protocol
was also evaluated.
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METHODS
Recruitment of Subjects
Only individuals who were diagnosed with FMS by a physician were qualified to
participate in this study. Subjects were recruited between June and November of 2005
from flyers and newspaper advertisements posted at BYU-Idaho and BYU-Provo,
through participant and physician referrals, as well as via an email sent to a community
information mailing list for employees of Intel-Oregon. Exclusion criteria included
pregnancy or the presence of any condition that would contraindicate being involved in
an unsupervised therapeutic exercise program as indicated by the participants’
physicians.
Subjects
Thirty-two individuals (30 females and 2 males) volunteered to participate and
were randomized into the study. Of those volunteers, eight were dropped from the study
due to non-response/withdrawal and three individuals did not meet the criteria for
compliance according to their physician’s diagnosis. One participant was noncompliant
and one provided insufficient data for the final analysis. Another nine individuals did not
complete the study in time to be included in this analysis. This resulted in nine
participants (mean age 48.22 ± 15.97; 9 females and 0 males) who were included for the
final statistical analysis. Figure 2 includes a flow diagram for the volunteers recruited for
this study.
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Average duration of symptoms for participants was 12.45 (± 12.8) years and the
average time since diagnosis was 5.02 (± 4.7) years. Average number of medications
taken daily was three (±3.7). Table 1 includes the demographic characteristics of the
participants.
Procedures
This study was approved by the Brigham Young University Institutional Review
Board prior to commencement. Participants were randomly assigned via pairwise block
randomization to the treatment video-exercise group or a treatment-as-usual control
group. Materials were sent to participants for data collection at baseline and after four
weeks of participation. All study materials were sent to participants via USPS mail. The
first packet contained (i) a written informed consent and a copy for them to keep, (ii) an
authorization form for the participants to sign that gave approval for the individual’s
physician to provide information regarding their FMS diagnosis for the purposes of this
study (this was included in order to comply with regulations regarding the protection of
healthcare information), (iii) a verification form for physician diagnosis which included
an area for them to provide us with the name and fax number for their diagnosing
physician, and (iv) a pre-addressed, stamped envelope to return the study materials.
Verification of physician diagnosis was determined by faxing the signed “Authorization
to Receive Healthcare Information” form along with a form that asked the physician to
indicate the criteria used for FMS diagnosis and also to approve the patient for
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participation in an unsupervised therapeutic exercise program. This form was modified
from one used by Rooks et al (26).
Upon receipt of confirmation of physician fibromyalgia diagnosis, the baseline
questionnaire materials were mailed via USPS mail. Four-week questionnaires were
mailed out prior to the time when the participant was scheduled to complete their
participation. All materials were returned by the participants using pre-addressed
stamped envelopes that we included in their packets.
Therapeutic Exercise Program
The treatment video-exercise group was mailed the exercise video along with
written instructions on how to start the program. The video consisted of a combination
of therapeutic exercises and activities, along with verbal and visual instruction as to how
to perform each activity. A listing of the exercises is included in Table 2. Participants
were instructed to conduct the exercises as directed in the 42-minute video or until they
experienced pain, fatigue, or exacerbation of symptoms. Each treatment participant was
also given a logbook in which they were to record the mode, frequency and duration of
any daily exercise sessions including those from the video as well any other exercise
treatments. The accounts in this logbook were used to determine compliance to the
exercise protocol.
This group was instructed to watch the video and conduct the prescribed
exercises at least 3 times per week. Each participant was instructed to continue with any
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other medications or treatments that they were conducting at the beginning of the study.
Questionnaires were completed at Baseline and after 4 weeks of continuous participation.
Control Group
The treatment-as-usual control group was instructed to follow their standard
treatment for FMS symptoms. They were also provided with a daily exercise logbook to
record any exercises that they conducted throughout the course of the study. This group
was also instructed to continue with any other medications or treatments that they were
conducting at the beginning of the study. Questionnaires were also completed at baseline
and after 4 continuous weeks in the study.
Outcome Measures
There is currently no single measure used for evaluating change in fibromyalgia
research related studies (27) and a wide variety of measures are commonly used. In a
comprehensive review of 16 high quality FMS studies, over 60 different outcome
measures were used (8). All of the instruments used in this study involve self-report
measures. However, patient questionnaires can be considered “as valuable as laboratory
or imaging data” in rheumatology care (28).
Health status. The Fibromyalgia Impact Questionnaire (FIQ) is a two-page selfadministered instrument developed for evaluation of health status with regards to
individuals who have FMS (29). This 20-item instrument has subscales designed to
measure physical function, work status, depression, anxiety, sleep, pain, stiffness, fatigue,
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and general well being. Items are measured on a Likert-type scale. Construct validity
and test re-test reliability have been established (29).
Self-efficacy. In order to measure change in participants’ perception of their
ability to cope with the pain and symptoms of FMS, the 8-item Stanford Arthritis Self
Efficacy Scale (ASES) was used. This one page instrument was developed to measure
patients’ self-efficacy with regards to management of their rheumatic condition (30).
This measure, developed by Lorig et al(30) consists of 8 items and is self-administered.
Reliability as well as construct and concurrent validity have been established (30, 31).
The ASES scale is used regularly in fibromyalgia research and is modified slightly in
which the term “fibromyalgia” was exchanged for the term “arthritis” throughout the
scale (31).
Pain and fatigue. As pain and fatigue are cardinal symptoms of fibromyalgia,
pain and fatigue were measured using visual and numeric analog scales. These scales
have been used previously and been found to be valid and reliable in previous chronic
pain research studies (32-34). Questions examined the pain and fatigue experienced over
the prior two weeks as well as pain and fatigue over the last month. These questions are
similar to the ones used in the Fibromyalgia Impact Questionnaire (29).
Global health. Self-reported global health is a common measure in fibromyalgia
research. Test-retest reliability has been demonstrated for this measure and has been
found to be an excellent predictor of future health (35, 36).
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Health distress. This four-item measure has been modified from the Medical
Outcomes Study Health Distress Scale. Internal consistency reliability and test-retest
reliability has been examined. This scale has been used effectively in chronic disease
studies (36).
Analysis
Compliance to the exercise program was determined by examining the exercise
logs that the participants returned. Individuals who conducted the exercises at least three
times per week and completed all of the questionnaires were included in the analysis.
Nine individuals were included in the final analysis. This analysis did not use intent-totreat. Results were analyzed by means of ANCOVA using the baseline and posttreatment scores for self-efficacy, pain, fatigue, self-rated global health and health
distress. The Baseline pre-test scores were used as the covariates to control for initial
group differences. Statistical significance was set at p< .05.
RESULTS
Table 3 illustrates the mean values for the baseline and post-treatment outcome
measures. This analysis did not reveal a significant effect for global health F(1, 6) =.14;
p =.7256; health distress F(1, 6) =.55; p = .4879; fatigue at 2 weeks F(1, 6) =.33 p
=.5846; fatigue at 4 weeks F(1, 6) =.21; p =.6627; pain at 2 weeks F(1, 6) =.01; p =.9090;
pain at 4 weeks F(1, 6) =1.18; p=.3197; or self-efficacy F(1, 6) =.74; p =.4229.
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DISCUSSION
Two key points of this therapeutic exercise program are first, that it is an
unsupervised, video-based program that is designed to be done at home and second, that
it is a light therapeutic exercise program that potentially can benefit individuals who are
either beginning to exercise or those who are already involved in a regular aerobic
exercise program. The primary purposes of this feasibility study were to determine if the
program could be tolerated without a significant exacerbation of FMS symptoms and
determine if the video exercise program could successfully be adhered to without
supervision. We determined that this pilot study of a 4-week therapeutic exercise
program had no statistically significant effects in improving self-efficacy, pain, fatigue,
self-rated health status or health distress in women who were diagnosed with
fibromyalgia. While the treatment group appeared to experience a greater improvement
than the control group for pain experienced in the prior 4 weeks, the results are not
statistically significant possibly due to the small sample size.
An essential aspect of any exercise treatment program is that the activity must be
tolerated (8). In our pilot study, only one participant indicated that she conducted the
“wrist roll” exercises too aggressively and also experienced lymphatic breast pain after
conducting the self-massage. No additional adverse effects were reported from
conducting the exercises as demonstrated. Participants did not report an exacerbation of
any fibromyalgia symptoms and this suggests that this program may be safe for FMS
patients. The exercises were safely conducted with no supervised training or
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personalized instruction from study personnel. Another possible benefit of this program
is that many of the treatment group participants subjectively indicated that they found the
exercises to be helpful in the management of their fibromyalgia symptoms. This suggests
that this program could be clinically beneficial in spite of the lack of statistical
significance.
High dropout and poor compliance rates are common in research dealing with
individuals who have fibromyalgia. Other home-based, unsupervised FMS exercise
programs have experienced high-dropout or poor compliance, and minor improvements,
if any were found (37-39). In a well-designed study of a video-based low impact
exercise program, problems of exercise adherence were evident in spite of the fact that
the researchers were diligent in explaining the exercises and protocol to participants (40).
The compliance rate for our study was 86%, indicating that most treatment participants
conducted the exercises at home at least 3 times per week as indicated in the written
study protocol. However, it is important to note that our study had such a small sample
size (N=9) that a true representation is necessary with a larger sample size.
One possible limitation in our study is that 78% of participants reported that they
were currently involved in regular exercise at baseline in the study. One study of an
individualized 12-week cardiovascular home-based exercise program noted greater
improvements and adherence in the program for women who had greater impaired
function at baseline (41). It may be that women who have lower levels of physical fitness
and greater levels of impairment may experience greater benefits from an exercise
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program. In addition, the advertisements for our study recruited individuals who were
interested in participating in a therapeutic exercise program. It is possible that we
recruited a sub-group of individuals with FMS who were already physically active and/or
were ready to adopt a new program or add to their existing regimen. While very few
FMS exercise studies actually use involvement in a concurrent exercise program as
exclusion criteria (8), it could be that physically active individuals with FMS would not
experience significant improvements by adhering to this therapeutic exercise program as
they are already involved in a regular aerobic exercise program.
In spite of the increasing amount of research over the last decade and a half, there
remains a lot of unknowns and controversy surrounding fibromyalgia (4). Additional
high-quality research is needed to determine effective home-based, therapeutic treatment
programs as they are low in cost and are well tolerated by fibromyalgia patients. This
specialized exercise program has several potential benefits. This program is designed to
be (i) used at home, (ii) unsupervised and requires little or no equipment (only requires a
VCR/DVD and a TV for the initial stages of learning the exercises), and (iii) used as an
adjunct therapy to complement a patient’s pre-existing exercise routine. With this
information from our pilot study, it appears that patients are able to tolerate this
intervention without an exacerbation of symptoms. While the results of this feasibility
study are statistically insignificant, a larger clinical trial assessing between-group clinical
outcomes is needed to determine the efficacy of this intervention.
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Table 1. Characteristics of Participants who Completed the Study

Characteristics

N (SD)

%

Female

9

100%

Male

0

--

Married

7

78%

Single

2

22%

Graduate School

2

22%

College

3

33%

Some College

3

33%

High School

1

11%

12.45 (12.8)

--

Years since diagnosis

5.02 (4.7)

--

Medications (per day)

3 (3.71)

--

Sex

Marital Status

Years of Education

Duration of Symptoms (years)
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Table 2. Therapeutic Exercises and Activities
Floor Exercises
Relaxation
Relaxed breathing
“Walking” in place
Neck rolls
Knee rolls
Diagonal arm movements (I and
II)
Diagonal leg movements (I and
II)
Trunk and hip stretch

Ankle rolls
Overhead reach
Hip and leg rolls
Wrist rolls
“Child’s pose”
Kneeling

Feet, legs, and thighs
Abdominal circles and press
releases
Lower rib clearing
Sternal release
Pectoral clearing
Neck clearing
Hands, arms, shoulders

Cheeks
Neck and shoulder
squeezes
Ears
Scalp
Jaw line
Nose

Postural alignment
Forward/backward bending
Standing arm raise I
Standing arm raise II
Scoop and push down
Cherry picking

Standing arm swings
Push-pulls
Push pulls and squats
“Parting the Mane”
Arm and leg shakes

Cobra position and
look back

Massage/Lymphatic Drainage

Posture Alignment, and
Standing Movement Series
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Table 3. Mean values (SD) for outcome measures

Control Group (N=5)

Treatment Group (N=4)

Post-Treatment

Post-Treatment

Scale

Baseline

(4 weeks)

Baseline

(4 weeks)

Global Health

3.2 (.4)

3.33 (.5)

4.0 (1.0)

4.0 (1.0)

Health Distress

2.4 (.4)

2.4 (1.2)

3.3 (1.6)

2.4 (1.3)

Pain (2weeks)

4.3 (2.1)

4.8 (1.8)

6.0 (3.5)

6.0 (2.0)

Pain (4 weeks)

48.7 (9.4)

51.7 (11.6)

55.7 (17.0)

52.7 (15.3)

Fatigue (2 weeks)

7.2 (1.2)

5.8 (1.7)

6.3 (2.1)

7.0 (1.7)

Fatigue (4 weeks)

1.2 (.7)

1.5 (1.0)

.9 (.4)

1.5 (.4)

ASES

4.9 (1.5)

5.9 (1.4)

3.3 (1.4)

5.5 (2.8)
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Figure 1. Location of Tender Points for Fibromyalgia Diagnosis (American College of
Rheumatology Criteria)
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Volunteered for study
participation

Treatment
N=16

Randomization

JIneligible = 2
JWithdrawal = 3

JIneligible = 1
JWithdrawal= 5

Eligible
n = 11

Compliant
n=4

Noncompliant
/ insufficient
data

n =2

Control
n = 16

Eligible
n = 10

Not finished
prior to Jan
31
n=5

Figure 2. Flow Diagram for Study Participants

Compliant
n=5

Noncompliant
/ insufficient
data
n =0

Not finished
prior to Jan
31
n=5
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Appendix A
Prospectus

26

27
Chapter 1
Introduction
Fibromyalgia is a perplexing syndrome that currently affects 3.7 million people in
the United States (1). Although it is a condition that most commonly affects women,
men and children have also been diagnosed. Prevalence has been estimated at 3.4% for
women and 0.5% for men (1, 2).
Fibromyalgia is a syndrome of unknown origin and multiple symptoms. The
American College of Rheumatology (ACR) has determined official criteria for
classification (3). The main criteria for diagnosis include widespread pain and tenderness
that must be experienced for at least three months. This pain must be experienced above
and below the waist, on the axial skeleton, as well as on both the right and left sides of
the body (3). In addition to this widespread pain, a significant distinguishing criterion of
the syndrome involves the palpation of tender points. Tender points are localized areas
of tenderness that do not have any additional characteristics such as raised knotty tissue.
For diagnosis according to the ACR criteria, mild or greater pain is experienced upon
palpation of at least 11 of 18 predetermined tender points when applied with a force of
4kg/cm. These tender points include areas such as the upper midpoint of the trapezius,
the upper outer quadrant of the gluteus maximus, and the knee at the medial fat pad
proximal to the joint line (3). It is important to note, however, that the tender point
criteria are often not strictly adhered to when a physician or rheumatologist diagnoses
individuals in a clinical setting (4) and there is also a debate as to whether these criteria
should be adhered to in clinical settings (5, 6).
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Fibromyalgia Syndrome (FMS) is often found with various co-existing conditions
such as depression, irritable bowel syndrome, and chronic fatigue syndrome (2, 4).
Although the exact cause of fibromyalgia is unknown, suggestions vary and include
theories such as low growth hormone secretion resulting from abnormal sleep patterns,
(7) an “aberrant central pain mechanism,” (8) and abnormal levels of Substance P (a
neurotransmitter responsible for increased pain perception) (9).
Due to the uncertain etiology and the comorbid conditions associated with
fibromyalgia, it has been difficult to determine effective treatment. One specific
standardized protocol for treatment of fibromyalgia has not yet been determined (4).
Treatment for FMS usually includes combinations of various pharmacologic and nonpharmacologic interventions (10, 11).
Although there are currently no medications that are specifically approved by the
FDA for the treatment of FMS, various medications are often used to treat symptoms.
Pharmacologic treatment may include various drugs such as nonsteroidal antiinflammatory agents (NSAIDS), tricyclic anti-depressants, and serotonin reuptake
inhibitors (4, 10). However, most of these drugs are ineffective in alleviating many of the
symptoms and are often associated with negative side effects (10, 12). It is estimated that
less than 50% of patients experience acceptable levels of relief due to these interventions
(see (4, 10, 13) for review).
Non-pharmacologic treatments are varied and have even included non-traditional
alternative medicine treatments such as hypnosis, (14) acupuncture, (15) chiropractors,
and reflexologists (16). Successful treatment strategies include behavior therapies,
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physical therapy, and exercise (10, 17, 18). Although the exact reason is not known,
exercise interventions have proven to be most effective in the treatment of FMS (19, 11).
Most successful treatment programs are multidisciplinary and should emphasize
education, exercise, some medications, as well as cognitive behavioral therapy (11, 17).
A home-based therapeutic exercise program has been developed by a practicing
physical therapist for individuals suffering from fibromyalgia and other forms of chronic
pain and has shown promise when applied to FMS patients in a physical therapy practice.
The proposed treatment intervention involves the use of an educational video that
describes various stretches and therapeutic exercises that facilitate reduction in
fibromyalgia symptoms such as pain and fatigue, as well as enhancing self-efficacy,
flexibility, and relaxation. The home-based therapeutic exercise program titled,
“Fibromyalgia: Keys to Recovery,” involves 42 minutes of activities such as therapeutic
exercises, stretching, breathing exercises, and light self massage.
Statement of the Problem
The purpose of this study is to evaluate the effects of a specialized therapeutic exercise
program designed to improve self-efficacy and physical functioning and decrease pain
and fatigue in fibromyalgia patients.
Hypothesis and Null Hypothesis
Hypothesis - The treatment group will experience a greater reduction in pain and fatigue
as well as increased improvement in self-efficacy and physical functioning over the
control group.
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Null Hypothesis - The treatment group will not have improvement over the control group
in the areas of pain, self-efficacy, and physical functioning.
Operational Definitions
Fibromyalgia or fibromyalgia syndrome (FMS) - A syndrome determined by the
presence of predefined areas of tenderness and characterized by widespread pain and
fatigue.
Tender point - A specific localized area of sensitivity or tenderness that is without
distinguishing external characteristics. Pressure upon a tender point will elicit pain.
Treatment-as-usual (TAU) - Determined as the current treatment or standard of
care that the individual is undergoing to treat the manifestations or symptoms of
fibromyalgia. For example, treatment-as-usual can vary from use of various treatments
including but not limited to pharmacologic drugs, acupuncture, massage, exercise, or no
treatment at all. This group will serve as the control group for this study.
Self-efficacy – Confidence or certainty that an individual can perform certain
tasks. Self-efficacy will be measured by the Stanford Arthritis Self-Efficacy Scale
(ASES).
Functional ability- Individual’s ability to accomplish daily, routine tasks.
Functional ability will be measured by the Fibromyalgia Impact Questionnaire (FIQ).
Assumptions
1. Each treatment participant will follow the instructions in the “Quick Start Guide”
that accompany the video and perform the exercises as recommended and detailed
in the exercise video.
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2. The treatment-as-usual or control group will not participate in any new exercise
program that they were not involved in at the initiation of the study.
3. Subjects are not to be current participants in any other trials.
4. Each subject is expected to truthfully report and log all activities or interventions.
Delimitations
1. The participants will be allowed to remain on any current pharmacological
treatments that they were on at the study initiation.
2. For this study, recruitment will involve volunteers that will be recruited in several
communities in Utah, Oregon, and Montana.
3. Due to the relatively rare occurrence of fibromyalgia among men, it is expected
that women will comprise the majority, if not all, of the subject sample.
4. As FMS has been rarely diagnosed in children and teens, we will only be
recruiting participants aged 18 years of age and older.
5. As this treatment intervention is a pilot study and designed for individuals who
have been examined by a physician and diagnosed with FMS, we will not exclude
participants if their diagnosing physician did not strictly adhere to all of the
diagnosis classification criteria established by the American College of
Rheumatology.
Limitations
Fibromyalgia is a syndrome and there are currently no diagnostic laboratory tests to
confirm diagnosis, therefore, fibromyalgia is largely a syndrome of pain and perception.
As a result of this, all outcome measures involve self-reported data gathered from the
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participants. However, all instruments to be used are used in FMS research studies. In
addition, Wolfe states that patient questionnaires can be considered “as valuable as
laboratory or imaging data” in rheumatology care (20).
Significance of the Study
Fibromyalgia is one of over 100 rheumatologic conditions contributing to pain and
disability in the United States, and is the second most commonly seen diagnosis in
rheumatologic practices (4). The prevalence of rheumatologic conditions is also expected
to increase significantly effecting an estimated 18% of Americans by 2020 (1).
Exercise is a recommended treatment for fibromyalgia, however, “proper
[exercise] prescription” still remains to be a crucial part in successful treatment (21).
Jones and Clark suggest that “less intensive” exercise interventions result in greater
compliance with participants and greater improvement regarding FMS symptoms (22).
Moreover, they also recommend that successful exercise programs need to introduce
activity gradually, lessen the chance of causing muscular microtrauma, and enhance selfefficacy which will increase the probability of exercise adherence (22). Most research
studies have been conducted on supervised exercise programs. These programs are often
costly, time consuming, and often experience low rates of compliance. Very little
research has been conducted regarding the implementation of an effective home-based
therapeutic exercise program designed specifically for individuals who suffer from
fibromyalgia. The proposed research study will contribute to essential ongoing research
to determine effective interventions in treating the symptoms and manifestations of this
perplexing condition.
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Chapter 2
Review of Literature
Fibromyalgia Syndrome (FMS) is a perplexing rheumatologic condition that
currently affects approximately 3.7 million individuals in the United States. Prevalence
estimates for this syndrome are 3.4% for women and .5% for men (1). Prevalence also
increases significantly with age with the majority of cases involving women who are 50
years of age and older (1, 2).
Individuals who have this syndrome experience symptoms that are often
considered disabling (23, 24). The most prominent characteristic involves chronic
widespread pain lasting for at least 3 months. Other distinguishing characteristics include
morning stiffness, fatigue, joint swelling, and sleep disturbances (2, 3, 24). Additional
documented symptoms that are fairly common include paresthesias (abnormal sensations
of the skin such as numbness), headaches, Raynauds phenomenon, Sicca symptoms (dry
eyes/mouth), and psychological distress such as anxiety and depression (1). Symptoms of
urinary urgency, excessively tender shin bones, and fascial pain have also been reported
(4).
Along with chronic pain and other discomforting symptoms, individuals who
suffer with FMS often suffer from various comorbid conditions. These separate
conditions include Chronic Fatigue Syndrome, Irritable Bowel Syndrome, depression,
Systematic Lupus Erythematosus, and Rheumatoid Arthritis (4). The simultaneous
presence of these conditions often poses difficulty in distinguishing fibromyalgia from
other concomitant diseases and/or conditions (4).
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Diagnosis Classification
Although fibromyalgia syndrome (FMS) is the second most common diagnosis in
rheumatology clinics (4) it is relatively new as a classified syndrome (3). Official
classification criteria for diagnosis were not established until a comprehensive report was
published by the American College of Rheumatology in 1990. The main criteria for
diagnosis include widespread pain that must be experienced for at least three months. The
pain is experienced above and below the waist, on both the right and left sides of the
body, as well as on the axial skeleton (3).
In addition to this widespread pain, another distinguishing criteria for diagnosis of
the syndrome involves the palpation of tender points (3). Tender points are localized
areas of tenderness that do not have any additional distinguishing characteristics such as
raised “knotty” tissue. For diagnosis, localized pain must be experienced upon palpation
on at least 11 of 18 predetermined tender points when applied with a force of 4kg/cm (3).
These tender points include areas such as the upper midpoint of the trapezious, the upper
outer quadrant of the gluteus maximus, and the knee at the medial “fat pad” proximal to
the joint line (3).
These criteria provide a specificity of 81% and sensitivity of 88% in
distinguishing FMS from other types of chronic pain conditions such as Rheumatoid
Arthritis (3, 4). While the criteria are not always used for diagnosis in medical practice,
the criteria have proved beneficial in providing a reference for researchers investigating
causes and effective treatment interventions
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Etiology/Pathogenesis of fibromyalgia
Fibromyalgia has been described as an enigmatic condition as the exact
pathogenesis and etiology of the condition have not been established. However,
substantial research has been conducted to pinpoint possible underlying factors
contributing to the cause and development of this syndrome. This section will address
several theories regarding the pathogenesis and etiology in fibromyalgia.
Since “nonrestorative” sleep is a common complaint associated with
fibromyalgia, (3, 25), sleep quality in FMS patients has been examined. The earliest of
these findings was conducted by Modofsky and Scarisbrick (26). They found that
fibromyalgia-like symptoms could be induced by interrupting slow wave or Stage 4 sleep
in healthy, sedentary controls (26). Lentz et al (7) also found that disrupting slow wave
sleep in individuals without decreasing total sleep in time resulted in discomfort, fatigue,
decreased pain threshold and the increased “inflammatory response” as a result of
pressure on the skin. In a review of several studies on sleep quality and FMS, Harding
concludes that a “distinct relationship exists between poor sleep quality and pain
intensity” (25). These studies all suggest that disturbed sleep may be one cause and/or
may contribute to the pathogenesis of fibromyalgia.
As a significant symptom of fibromyalgia lies in the sensation of muscular pain,
early research was also primarily focused on muscle and soft tissue irregularities. In a
review of skeletal muscle abnormalities with FMS, Olsen and Park reviewed 8 studies
that examined biopsies of trapezius or quadricep muscles of FMS patients. Findings were
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noted such as “moth-eaten fibers, “rubber band morphology “abnormal mitochondria,”
“compromised capillary circulation,” and “reduced number of capillaries” (27).
Due to the fact that FMS patients often exhibit reduced muscular strength and
force, muscle metabolism has also been addressed in several studies. While reviewing
studies of muscle metabolism and FMS, Olsen and Park (27) found that several studies
demonstrate that PCr and ATP levels have been found to be lower in FMS in addition to
reduced oxidative capacity and energy reserves. They conclude that these results could
be due to damaged mitochondrial function and result in compromised muscle repair
processes which in turn may bring about the pain and fatigue experienced in FMS (27).
However, the results of many of these studies have methodological flaws, and the
presence or absence of muscle tissue abnormality has been debated. Simms authored
several articles on the subject and concludes that most FMS biopsy studies demonstrate
“nonspecific or normal findings” and suggests that the evidence indicates that
fibromyalgia is due to a central mechanism as opposed to a peripheral or muscular
mechanism (28, 29).
The concept of a central mechanism in fibromyalgia has been frequently studied.
In an effort to understand pain perception in FMS, Bendtsen et al compared the stimulus
response function in muscles of FMS patients vs. normal controls. They conclude that
nociception is qualitatively altered in the muscles of FMS patients and suggest that
fibromyalgic pain may be a result of an “aberrant central pain mechanism” (8).
This central pain mechanism in FMS may be the result of several factors.
Substance P plays an important role in “the transmission of pain from the periphery to the
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central nervous system” (9). Substance P is mediated by serotonin, which also
contributes to sleep and pain mechanisms (9). Cerebrospinal fluid levels of Substance P
in FMS patients were compared against levels taken from normal subjects. Results
demonstrated that Substance P levels were found to be significantly higher by as much as
3 times in FMS patients compared to the healthy control group. Russell concludes that
this increased level of Substance P may be a contributor to the decreased pain threshold
in FMS patients (9). Cerebral blood flow has also been noted to have significantly
decreased levels in FMS patients and may contribute to abnormal nocioceptive function
(30, 31). While reviewing single photon emission photography (SPECT) procedures,
Mountz et al concludes that abnormal pain perceptions may be sustained by
modifications in proper function of the central nervous system function (31).
Zimmerman also agrees that nociception plays an important role, and maintains that the
exact mechanisms are still elusive and more research is needed (32).
Several researchers have examined the function of the various neuroendocrine
axes and their possible contributions to the cause of fibromyalgia. Crofford et al (33)
reviewed consistent neuroendocrine abnormalities found in the hypothalamic-pituitaryadrenal axis (HPA) and the hypothalamic-pituitary-gonadal axis (HPG). They
hypothesize that the neuroendocrine abnormalities in FMS may be triggered by stress
from a disease, injury, or from a psychological stressor. This “stressor” in turn leads to
dysfunctional communication between the brain and the body and contributes to the
development of fibromyalgia (33).
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One review examined the musculoskeletal system, the neuroendocrine system and
the central nervous system to determine possible links and contributing factors to FMS.
Weigent concludes that a genetic susceptibility to physical/psychological stress leads to
abnormalities within the neuroendocrine system. Muscular “microtrauma” or injury then
leads to increased pain perception and pain threshold levels (34).
While the exact mechanisms still remain elusive, there is definitely a consensus
that fibromyalgia pathogenesis and etiology is complex and multifaceted (32). Continued
research will contribute to knowledge about fibromyalgia and ultimately result in more
effective treatment strategies.
Treatment Interventions
Due to the uncertainty regarding exact mechanisms contributing to FMS,
treatment interventions have been largely focused on theoretical observations (13). It has
been widely stated that currently there is “no single highly effective treatment” for
fibromyalgia (4). However, extensive research has been conducted to discover various
ways of treating and managing this syndrome. Treatment usually involves the
management of symptoms such as sleep irregularities, psychological factors, restoring
functional physical fitness and activity levels, and addressing problems associated with
concomitant illnesses (35).
Although most patients use a combination of therapies, this review divides FMS
treatment strategies into two main categories of pharmacologic and non-pharmacologic
treatments. A specific emphasis is placed on reviewing exercise-based treatment
programs.
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Pharmacological Interventions
Although there are currently no medications that are approved specifically to treat
FMS, pharmacological treatments are commonly used among FMS patients (36) and are
generally based on alleviating symptoms of pain and sleep disturbances (37). Two metaanalyses and several reviews were analyzed to briefly summarize the effects of the most
commonly prescribed medications with FMS. These FMS pharmacological medications
will be classified into three categories consisting of (1) anti-depressants, (2) analgesics
and anti-inflammatory agents, and (3) other agents.
Antidepressants. Antidepressants have long been used to manage and treat pain
in individuals and it is important to note that the analgesic effects “are independent of
their effects on clinical depression” (38). Due to their analgesic properties and effects in
improving sleep, antidepressants have been commonly used as a component in the
management of fibromyalgia (39, 36, 40). Antidepressants most commonly used in the
management of FMS include Tricyclic Antidepressants (TCAs) as well as SerotoninSpecific-Reuptake Inhibitors (SSRI’s) (36).
According to a 7-year study investigating the use of various treatments with
fibromyalgia patients, TCA’s were used by 57% of the FMS population over a 7-year
period (36). Amitryptaline is the most commonly prescribed (36) and studied TCA drug
although other TCA’s have also been studied (41). In a review of four controlled, and
blinded studies investigating the efficacy of amitryptaline; Inanici notes improvements
with various outcomes including morning pain/fatigue, sleep quality, subjective pain, as
well as patient and physician global assessment (35).
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Few contraindications are known for TCA’s and they are non-addictive. However
adverse effects may include sicca symptoms, postural hypotension, weight gain,
constipation, and exacerbation of cardiac arrythmias (35, 42). Godfrey also emphasizes
the fact that absorption and pharmacological effects may vary greatly among individuals
(42). It is important to note that at best only half of patients actually show a significant
improvement in their symptoms as a result of TCA treatment, (18, 42) and the beneficial
effects diminish over time (43).
Due to the relative success with TCAs in treating symptoms of fibromyalgia,
SSRIs or Selective Serotonin Reuptake Inhibitors have also been investigated (10).
Wolfe approximates that 11% of FMS patients used an SSRI over a 7-year period (36).
Several SSRI’s have been examined in the treatment of fibromyalgia including
citalopram, fluoxitine, and sertraline. However, fluoxitine has been most common SSRI
studied in the treatment of FMS. While SSRI’s may improve FMS symptoms with
regards to a few outcome variables, their most beneficial effects involve alleviation of
concomitant depression as well as improvement with sleep quality (10). Pain and tender
point pain are usually not significantly affected. In a review on antidepressants in the
management of pain, Cohen, indicates that most trials indicate TCA’s to be “superior” to
SSRI’s and states, “in most circumstances, TCAs should remain the first-line
antidepressants for chronic pain (38).”
In a meta-analysis of 13 randomized trials studying the effects of anti-depressant
medications on FMS symptoms, O’Malley concludes that this class of drugs are effective
at improving symptoms such as pain, poor sleep, and fatigue (40). However, it is
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important to note that only 25-30% of individuals will obtain clinically significant
improvements as a result of antidepressant therapy treatment (18).
Analgesic and Anti-inflammatory Agents. Despite a lack of convincing evidence
(43), analgesic and anti-inflammatory agents have been used extensively by patients
suffering with fibromyalgia (36). Non-steroidal anti-inflammatory drugs, or NSAIDs, are
the most commonly used drugs among fibromyalgia patients (36), and have been
described as the “mainstay of drug treatment” for musculoskeletal conditions(41).
Approximately 81% of fibromyalgia participants at 6 centers had used NSAIDs over the
course of 7 years, and 54% were currently using these drugs (36). It is also estimated that
aspirin and acetaminophen are used by 50% and 60% of FMS patients respectively (36).
A meta-analysis conducted by Rossy et al (37) found that trials involving NSAIDs
alone did not result in improvement on any outcome variables. Curatolo (41) also notes
that NSAIDs have “limited effectiveness” with regards to musculoskeletal pain and notes
that the “published evidence does not support the widespread use” (41). Similar
conclusions have been made by Millea (44) and Alarcon (43). Negative side effects from
the long-term use of NSAIDS include gastrointestinal and kidney problems (10).
Narcotic analgesics include drugs such as tramadol, codeine, and opioids (10) and are
used by approximately 20% of FMS sufferers (36). However, prescription is not
recommended as few trials have been conducted and results do not justify their use(10,
35).
Other Agents. Several other agents have been examined with regards to treatment
of FMS. Three of these drugs will be briefly discussed. Anxiolytics are used by
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approximately 43% of FMS patients (36). Alarcon (43) states that the only beneficial
anxiolytic drug that has been studied in fibromyalgia is alprazolam, although other drugs
are frequently prescribed. One double-blinded placebo controlled trial of ibuprofen with
alprazolam found small improvements with regards to tender point and general pain (45).
Alprazolam has demonstrated to have sedative effects and long-term use leads to
dependency (10).
S-adensyl-L-methionine or SAMe has been studied due to its anti-depressive,
analgesic, and anti-inflammatory characteristics (10). A few controlled trials have found
SAMe to be more effective than a placebo in reducing symptoms of depression, pain, and
tender point count (43). While no significant side effects have been documented, SAMe
has not been approved as a prescription medicine in the United States (10).
Wolfe found that roughly one quarter of FMS patients have used Cyclobenzaprine
at some point in time (36). Cyclobenzaprine is a skeletal muscle relaxant that is often
used as an antidepressant and has been found in a few studies to improve sleep and pain
severity (10). Inanici and Yunus summarized four studies ranging in length from 10 days
to 6 months (35). Three of the four studies reported improvements in areas such as
fatigue, stiffness, pain severity, and sleep. However, the longest study reported no
benefits at 3 and 6 months into the study (35). Possible side effects of cyclobenzaprine
include anticholinergenic and effects on the central nervous system (10).
In conclusion, Goldenberg notes that only 30%-50% of patients can expect to
have improvements as a results of pharmacologic treatments (4), however, a 7 year
outcome study showed that the average number of drugs taken by FMS patients was eight
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(36). The results of a meta-analysis conducted on 49 fibromyalgia treatment
interventions concluded that only antidepressants and muscle relaxants were associated
with improvement based on physical status measures. The outcome measures of daily
functioning were not improved via any pharmacological-based interventions (37).
While pharmacological treatment may play a role in alleviation of some
symptoms of fibromyalgia, additional treatments need to be investigated. In a review of
pharmacological treatment of various musculoskeletal disorders, including fibromyalgia,
Curatolo (41) states, “It seems that prescribing drugs satisfies a humanitarian urge by
offering some degree of pain relief. This may be a valuable achievement in the context
of daily pain, but if complete resolution of pain and disability is the aim of the treatment,
we must admit that there is no pharmacological therapy by which these goals can be
reached.”
Non-pharmacological Interventions
Due to poor pharmacological management of FMS, patients often seek other
forms of treatments. Non-pharmacological interventions are usually based on addressing
a wide a range of problems associated with fibromyalgia and its symptoms. Nonpharmacological treatments are varied and even include non-traditional practices such as
herbal supplements or dietary modifications, reflexology, and chiropractors (16).
However, three common non-pharmacological treatment interventions will be described
for this review; Mind-Body Therapies, Acupuncture, and Exercise. A specific emphasis
will be placed on the exercise-based interventions.
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Mind-Body Therapies. Mind-Body Therapies are varied and can include therapies
such as “autogenic training, relaxation exercises, meditation, cognitive behavioral
training, hypnosis, guided imagery, biofeedback, and education” and have been
investigated in the treatment of fibromyalgia (46). Several studies have combined
various mind-body therapies with exercise-type programs and will be addressed in the
“Exercise” portion of this review.
After noting successful treatment of some types of conditions with psychological
factors, Haanen conducted a study comparing a hypnotherapy treatment group to a
physical therapy control (14). Forty patients were randomly assigned to the 12-week
programs. The hypnotherapy group reported significant improvements with regards to
pain, fatigue, and sleep variables. However, the authors note that because subjects were
“refractory” to physical therapy, the hypnotherapy group was being compared to a
treatment that had previously not been successful for them (14).
In a literature review of mind-body therapies (MBT) conducted with FMS,
Hadhazy found that exercise was found to be more beneficial than mind body therapies
alone. While it is noted that MBT may assist with increasing self-efficacy, “there is no
evidence to justify using mind-body therapies in place of other active therapies to either
modulate pain or improve function (47).”
Acupuncture. Acupuncture is an ancient form of Chinese medical treatment that
dates back thousands of years (48). It is a fairly common non-traditional therapy that is
used for treatment of various illnesses and conditions including FMS (16, 49). Treatment
involves the insertion of needles placed in specific areas of the body. The theory of
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placement involves the correction of or releasing of energy flow or “qi” (15, 48). The
mechanisms of action behind acupuncture are not clearly understood. Although most
theories center on its analgesic effects some suggestions include the stimulation of the
hypothalamus and pituitary glands and the releasing of endogenous opiods (49).
Few studies have examined the efficacy of acupuncture in the treatment of FMS.
The most oft-cited study was conducted by Deluze and colleagues (50) and contained the
“highest methodologic quality” (15). They conducted a double-blind randomized
controlled trial comparing an electroacupuncture treatment group with an acupuncture
sham treatment. After 3 weeks, the researchers found that the electroacupuncture group
improved significantly over the sham treatment group in areas such as pain and sleep
quality (50). Berman reports that these results are similar to six other lower quality
studies that also examined fibromyalgia and acupuncture (15). However, additional high
quality studies need to be conducted with long-term follow-ups to more effectively
scrutinize the effects (15).
Adverse effects of treatment with acupuncture are rare, but include skin
infections, fainting, bruising, and tissue or nerve damage (33). It is also important to note
that some patients may be classified as “non-responders” and may have no positive
effects from acupuncture treatments (15, 49). An NIH consensus panel of experts deemed
acupuncture to be useful as an “adjunct treatment,” an “acceptable alternative,” or to be
included in a “comprehensive management program” for fibromyalgia (49).
Exercise. Regular exercise has long been known for improving various aspects of
health. In addition to reducing risk of chronic health diseases such as cancer and
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cardiovascular diseases, exercise has proven to assist with weight loss or maintenance,
promotion of healthy muscles, joints and bones, as well as improving psychological
components of health such as reducing depression and anxiety.
Exercise has also proven to have beneficial effects in the treatment of
fibromyalgia and is the most oft studied non-pharmacological treatment intervention.
Interest in exercise as a significant component of FMS treatment programs initially began
with the observations of Modofsky et al (26). In a study examining sleep physiology, they
noted that fibromyalgia sufferers were more likely to experience non-refreshing sleep
than healthy controls. While noting that exercise has positive influence on delta sleep,
they also studied several healthy volunteers who exercised regularly and subjected them
to Stage 4 sleep deprivation. These subjects did not experience increased pain or other
symptoms that are noted with Stage 4 sleep deprivation (26).
In addition to these results Bennett et al found that 80% of fibromyalgia patients
had lower levels of aerobic fitness compared to sedentary controls and pre-published
standards (51). Borman investigated muscular strength as well as endurance in FMS
patients (52). Results showed that FMS sufferers had decreased quadriceps strength and
reduced aerobic performance capacities compared to healthy controls (52). However a
study conducted that examined cardiorespiratory fitness and perceived in exertion in
FMS patients versus healthy control subjects found that FMS patients had similar fitness
levels as that of healthy control subjects, but a difference was seen with regards to a
higher perception of exertion with the FMS patients (53).
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A comprehensive literature search was conducted using software developed by
the Dialog Corp (REF) and PubMed using the search terms fibromyalgia and exercise or
physical activity. The bibliographies of articles found were also examined to include any
articles that may not have come up during the computerized search. To be included in
this review, articles must be written in English, published in a peer-reviewed journal prior
to December 2004, and databased. Articles that were published in abstract form only
were not included in this review.
Several studies are reviewed that included some form of exercise alone or in
combination with other components such as education or cognitive behavioral therapy.
The interventions ranged in length from approximately 4 weeks to 24 weeks. The studies
involved various forms of exercise including aerobic activities, such as pool exercise or
walking, to strength training and flexibility/stretching programs.
For the purposes of this review, the studies were divided into three categories as
follows: (1) Studies that examined mainly an aerobic component of exercise, (2) studies
that included significant strength/resistance training or passive exercise components into
the programs, and (3) studies that involved a multidisciplinary approach which includes
an specific educational component.
1. Aerobic exercise interventions. Several studies examined interventions that
included mainly an aerobic exercise component for the intervention. The earliest of these
studies, and most frequently cited, was conducted by McCain and colleagues (54). A 20week supervised cardiovascular training program was conducted with 18 fibromyalgia
patients using bicycle ergometers. Results of the training group (CVR) were compared
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with a control group (n=20) that conducted simple flexibility exercises (FLEX).
Significant improvements were noted in the CVR group in pain threshold levels,
physician and patient global assessments, as well as in peak work capacity over the
FLEX control group. The authors also noted a “trend towards significance” in the patient
visual analog scales of reported pain and conclude that exercise may offer “some
therapeutic benefit” for FMS sufferers although the exact mechanism is not known (54).
Meiworm et al (55) examined the effects of a 12-week program of walking,
jogging, cycling, or swimming compared to a sedentary control group. The exercise
group exercise for approximately 20 minutes 2-3 times per week at 50% VO2 Max. The
exercise training improved aerobic fitness levels of the patients in the group with no
significant negative side effects. The program also had a positive influence on patient
wellness, tender point count, and painful body surface area (55). In a 20 minute modified
low-impact aerobics program, Mengshoel et al (56) also found no exacerbation of FMS
symptoms and improved dynamic upper body strength. However, no significant
improvements were seen with measures of pain, pain coping, or fatigue (56).
In a similar study, Gowans et al (57) conducted a randomized 23-week exercise
program to examine the effect of exercise on mood and physical functioning. Significant
improvements were noted with aerobic measures as well as depression and other outcome
measures (57).
Redondo and colleagues conducted a randomized parallel trial in which they
compared 8 week of supervised physical exercise to 8 weeks of cognitive behavioral
therapy(58). Significant improvements were seen in both groups at the end of the 8-week
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interventions especially with regards to physical activity improvements in the exercising
group. Follow-up at 6 months and one year, however, resulted in outcome measures
returning to baseline values (58).
In an effort to compare the effects of land-based exercise vs. pool-based exercise,
Jentoft et al (59) conducted a 20-week program to compare the two types of exercise.
While both groups improved with regards to cardiovascular fitness measures and fatigue,
the pool-based exercise group experienced greater improvements in a few other outcome
measures such as anxiety and depression (59).
Not all fibromyalgia exercise programs have found significant improvements with
regards to outcome measures. Since most exercise programs for patients who suffer from
FMS are supervised, Ramsay et al conducted a study to compare the effects of a 12 week
unsupervised home-based program (60). Patients were assigned to two groups. One
group met one time with a physical therapist to receive instruction and information on
how to perform the home-based program. The second group met one time per week with
the physical therapist to get instructions for the program as well. Due to low compliance
with the programs and lack of significance in improvements with regards to the outcome
measures, the authors regrettably state,” the results of this study are disappointing” (60).
Norregaard et al also failed to find significance in pain, fatigue, depression, aerobic
capacity, and muscle strength outcome measures when comparing a 12-week dance
program to a steady exercise program and a control group (61).
In a 24-week unsupervised walking program at varying intensities, Meyer and
Lemley (62) also found no significant changes due to low compliance and high dropout
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among subjects. After noting similar inconclusive results, Nichols and Glenn
recommended more studies to examine various types of exercise, studies that control for
“social effects,” studies that included larger numbers of subjects, as well as studies that
measures actual aerobic improvements in cardiovascular programs (63).
Due to success of some stress management programs, Wigers and colleagues (64)
conducted a study to compare the effects of a physical exercise program to a stress
management program as well as a treatment as usual control group. The aerobic exercise
group met 3x a week for 45 minutes for 14 weeks. The stress management group
received instruction regarding stress management and met for 90-minute sessions 2x a
week for 6 weeks, then only once per week for the remaining 8 weeks. Both of the
treatment groups showed significant improvements with regards to tender point
tenderness compared to the control group. The aerobic exercise group also experienced
improvement regarding pain distribution and work capacity. While noting that both
groups demonstrated positive short-term effects due to the interventions, at a 4-year
follow-up no significant long-term effects were found (64).
Sackner and colleagues conducted a well-designed randomized control trial
investigating the effects of a home-based videotape low impact aerobic exercise program
on FMS symptoms (65). Volunteers were recruited into one of three groups: exercise
training with one bout of exercise per day, training with two short bouts of exercise per
day and a no exercise control group. After 16 weeks of progressive training, no
significant differences were noted between the two exercise groups and only small
differences were found with improvements of symptoms and physical functioning (65)
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2. Strength Training and Passive Exercise Interventions. Due to the observations
of a lower aerobic capacity in individuals with fibromyalgia (51), a majority of the
studies have been conducted almost entirely on cardiovascular training programs. Rooks
attributes the lack of strength training research to apprehension regarding “risk for subject
injury and exacerbation of symptoms” (66). Several researchers have examined the
safety and efficacy of exercise programs for FMS patients that involve specific strength
training components. Several studies included interventions that had significant
components involving weight training.
The earliest of these studies was conducted by Martin and colleagues (67). They
examined a 6-week long exercise program that had a strength-training portion in addition
to time devoted to aerobic exercise and flexibility. Thirty-eight subjects were randomly
assigned to the training group or a flexibility control group. The training group
participated in a 1 hour long training session 3x per week for the 6-week program (67).
A significant decrease was noted in the training group in tender point counts as well as
degree of tenderness. No difference were observed with reference to self-efficacy, or in
the Fibromyalgia Impact Questionnaire (FIQ) designed to measure functional ability and
several other psychological components. However, the researchers did note a trend
towards significance with these variables. Recommendations were given to conduct
studies that lasted longer than 6-weeks, as well as possibly initiating a more intensive
program (67).
Rooks et al also conducted a similar study examining a multi-component exercise
program that contained cardiovascular flexibility and strength training elements (66).
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They found that the 20-week self-paced program (with exercise sessions 3x per week) did
not aggravate the FM symptoms and no musculoskeletal injuries were reported. The
authors cite a significant increase in muscle strength as a major study finding, and
conclude the program to be “safe, feasible, and beneficial” (66).
Hakkinen et al decided to investigate the results of a weight-training program of
healthy women compared to women who had fibromyalgia (68). After 21 weeks, they
found that the fibromyalgia training group had increased their strength to the same extent
as the healthy control-training group. Compared to a second control group of
fibromyalgia women who did not train, the fibromyalgia training group decreased
significantly in measures of neck pain, depression, and fatigue (68). Two other studies
were conducted by Hakkinen et al and Valkeinen et al examining similar 21-week
strength training programs to investigate neuromuscular function and the effects of
strength training in elderly women with FMS . Similar improvements were noted (69,
70).
Karper et al (71) also examined a program of aerobic exercise and resistance
training with machine weights. Participants exercised 3x a week for 6-12 months. A few
participants (n=3) also chose to remain in the study and exercise 5x per week for an
additional 6 months. The authors note that; “ all of the groups in the program were
helped to some extent on numerous fitness variables” (71). In 2003 they published an
article on 4 participants that were still following this program after 3 years and 3
participants who had been following it for 2 years. All participants continued to maintain
improvements over the additional follow-up period. Although this follow-up sample size
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is small, this demonstrates that it is possible to maintain long term exercise programs and
benefits in a supervised program (72).
Jones et al conducted a muscle-strengthening program and compared it to a
simple supervised stretching program (73). After 12 weeks, improvements were seen
with both training groups; however, the “magnitude of change” was greater in the
strength-training group than in the flexibility control (73). Geel also conducted a fairly
similar 8-week strength-training program and found comparable results (74). However,
the study did not contain a non-exercise control group and only 9 of 12 subjects remained
in the study through the conclusion (74).
Due to the potential anti-inflammatory effects of nitric oxide concentrations in the
bloodstream, Sackner and colleagues examined passive whole body periodic acceleration
on FMS symptoms. After 15 sessions on the motion platform device, improvements
were noted in the areas of energy, pain, and sleep. However, the sample size was small
(5) and no control group was used (75).
T’ai Chi exercise combines mind-body therapy with therapeutic exercise and was
investigated by Taggart and colleagues in a 6 week study (76). After 12 training
sessions, perception in health status and physical functioning improved significantly (76).
Although no control group was used, these exercises are beneficial as they are slow,
gentle movements and can be practiced at home after the movement sequences have been
learned (76).
3. Multidisciplinary Interventions. Several studies examine multidisciplinary
interventions that include exercise along with some sort of a cognitive/education
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component. In a review regarding management of FMS Goldenberg states that there is
strong evidence in support of patient education (11).
The earliest multidisciplinary program was conducted by Burkhardt and
colleagues (77). Patients were randomized into 1 of three groups receiving education,
education and exercise training, or a control group. The 12 week combination program
included six 1 ½ hour long education classes and 1 hour of physical training a week.
Participants were encouraged to also exercise on their own. Although there were no
significant differences between the two intervention groups, both programs reported
significant increases with self-efficacy and general quality of life measures. Although
71% of the experimental group subjects reported the program as “positive”, the authors
note that they did not collect information regarding the actual exercise actions of the
patients (77).
In the longest of the multidisciplinary interventions, Mannerkorpi et al examined
a 6 month long pool exercise program combined with a six session education program.
The pool exercise was conducted just one time per week for 35 minutes (78). Compared
to a control group, the combination group experienced significant improvements in 6
minute walk distance and the FIQ. While the exercise was not designed to specifically
improve aerobic capacity, the researchers report that the program was designed to
encourage physical activity as well as coping strategies. However, ½ of the participants
reported positive changes in their lives such as increased levels of physical activity (78).
Mannerkorpi and colleagues conducted a follow-up of this program 6 and 24 months
after completion on this treatment program. Although few participants reported
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continued pool exercise, most were still regularly conducting some form of physical
activity and participants continued to report improvements compared to their pretreatment values (79).
Gowans et al (80) also examined a pool exercise program combined with a 1 time
per week education class. Compared to the waiting list control group, the intervention
resulted in a significant increase in the 6-minute walk test, well being, and fatigue
experienced in the morning. These benefits were maintained through a 6-month followup (80). Cedraschi and colleagues conducted a similar randomized program involving a
6-week pool exercise and education classes. They also noted sustained improvements not
only after the 6 week program, but at 6 months follow-up as well (81).
Buckelew et al randomized participants into 4 groups receiving
biofeedback/relaxation training only, exercise only, combination, or an
educational/attention control group (82). No significant differences were found between
the three treatment groups. However, all three of the treatment groups experience
increases in self-efficacy as well as a lack of deterioration in tender point scores
compared to the control. At a 2 year follow-up the combination group had reported
results that were considered to be the best maintained (82). Van Santen and colleagues
also conducted a 24-week program comparing an aerobic fitness program, biofeedback
training, and a control group. Compared to the control group, neither treatment group
experienced any significant improvements with regards to any outcome measure.
In a similar study, Mengshoel et al (83) examined a multidisciplinary program
that included a cognitive portion with goal setting, addressing dietary factors, and other
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topics along with relaxation techniques, body awareness exercise and strengthening and
stretching exercises. The 10-week program resulted in an improvement regarding general
pain intensity, but no significant changes regarding measures such as sleep or fatigue.
Significant reductions in pain intensity were maintained through a 6-month follow-up
(83).
A 12-week program was conducted by King et al in which they randomized
participants into aerobic exercise and education, aerobic exercise only, education only,
and control groups(84). The exercise programs consisted of various activities conducted
3 times per week including walking and pool exercises. The education groups met once
per week for approximately 1-2 hours. After 12 weeks, the combination group reported
increased coping ability with regards to FMS symptoms. Of note, however, at 6-month
follow-up fitness improvements were maintained only with the exercise only group and
not with the combination group. As with many FMS studies, however, full compliance
with the actual programs was difficult (84).
Four studies examined pre-existing exercise-based programs with fibromyalgia
patients. In a unique month long outpatient program, Mason et al (85) examined the
efficacy of the Presbyterian Pain Treatment Program with FMS patients. The patients
attended the full-day program 6 days per week for 1 month. The treatment plan included
4 hours of exercise including walking and work on exercise equipment along with a
cognitive/educational component, and physical therapy with posture and flexibility
exercises. Beneficial effects with psychological outcomes, and subjective pain were seen

57
after 1 month and at 6-month follow-up. The most significant measure was a marked
decrease in depression (85).
Bailey et al also examined a pre-existing program with FMS patients (86). FibroFit is a FMS exercise program designed by the Arthritis Foundation. This program
included 3 sessions per week of a graded stretching, strengthening and aerobic exercise
along with education and counseling session 1 time per week. At 12 weeks, significant
improvements were found among various measures including aerobic fitness, upper body
strength, flexibility, pain, and disability (86).
Kendall et al compared two exercise/therapy regimens in a 20-week study (87).
The Mesendiak System (MS) consisted of 18 individual and 2 group sessions 1 time per
week. The sessions consisted of one-on-one education with a physical therapist along
with information regarding things like relaxation, breathing, balance, and posture. This
program was compared with Body Awareness Therapy (BAT) conducted with a group 1
time per week for 90 minutes. The BAT consisted of 3 components including discussion
on topics such as stress, instruction regarding body awareness movements, gait, balance,
posture, and breathing, as well as awareness of relaxation and tension techniques. The
BAT program participants experienced a decrease in global health after the study, but
regained it after an 18-month follow-up. The MS group experienced increases in pain,
overall impact, and self-efficacy and maintained these benefits through the 18-month
follow-up (87).
In an effort to examine a Qi Gong exercise program with an educational
component, Creamer et al conducted an 8-week study (88). The 2.5 hour sessions were
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conducted 1 time per week and consisted of 30 minutes of cognitive/behavioral education
training, 1 hour of meditation/relaxation, and 1 hour of Qi Gong exercise and movement
therapy. Improvements were noted in pain outcome measures, 6 minute walk test as
well as in the FIQ. These results were maintained up through the 4-month follow-up
period. It is important to note, however, that with all of the four previously mentioned
studies no control group was used (88).
Conclusion
In the United States, rheumatic conditions such as fibromyalgia, arthritis and
other musculoskeletal disorders are the leading cause of disability in individuals over the
age 65 years(1). The prevalence of rheumatologic conditions is also expected to increase
significantly effecting an estimated 18% of Americans by 2020 (1). As fibromyalgia is
the second most common diagnosis in rheumatology practices, significant research needs
to be conducted in management of this syndrome (4).
Since the ACR criteria were established in 1990, there has been a significant
increase in the number of published scientific articles that have examined various aspects
of fibromyalgia (89). While some research has been conducted to pinpoint possible
causes, additional research needs to determine the most effective treatments. In a three
year study on pain and pain relief in fibromyalgia patients, most patients reported that
exercise had the most beneficial effects compared to other treatments such as
pharmacologic therapy and alternative medicine (90). It is recommended that the optimal
treatment for FMS would include nonpharmacologic interventions, specifically exercise,
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education, and cognitive behavioral therapy, in addition to appropriate medication
management as needed for pain and sleep problems (4, 11, 37).
In 2002 a comprehensive report by the Cochrane Collaboration examined
published research involving exercise and fibromyalgia syndrome (19). They found that
supervised aerobic exercise programs proved advantageous with regards to physical
functioning and some FMS symptoms. They report a need for additional studies to be
conducted on programs that address strength training, flexibility, as well as long term
benefits of exercise programs (19). A majority of the previously reviewed exercise
intervention studies have documented the beneficial effects of various combinations of
exercise programs on its effects on fibromyalgia and its symptoms. However, limitations
are seen in many of the studies such as high participant dropout, poor compliance to the
exercise regimen, small sample sizes, and lack of appropriate control groups. Most of the
studies required supervision and lengthy amounts of time committed by the participants
as well. This adds up to an increased cost for the patient and for health insurance
companies.
Although exercise programs can be beneficial, “Proper prescription is the key
element,” as FMS symptoms are often exacerbated upon the initiation of an intense
exercise program (21). Therefore, it is recommended that individuals with FMS begin
with a gentle exercise program and then add on aerobic activities (21, 22, 91, 92).
Therefore, additional research is needed on low-intensity exercise programs that lessen
the chance of symptom exacerbation and increase long-term exercise adherence (22, 91)
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as well as “home program(s) of muscle stretching, gentle strengthening, and aerobic
conditioning” (48).
The proposed specialized exercise program has been designed to have several
potential benefits in addition to its therapeutic effects. This program is designed to be (1)
used at home, (no travel time is required and it can be done at any time during the day)
(2) requires no supervision and very little equipment (only requires a VCR/DVD and a
TV), and (3) it can be used as an adjunct therapy to complement a patient’s pre-existing
exercise regimen.
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Chapter 3
Methods
Subjects
Thirty subjects will be recruited, with a significant portion of the participants
expected to be female (1). Prior to any recruitment, IRB approval will be obtained
regarding the recruitment and participation of the subjects in the study. Since this
version of the video is in English, participants must be able to understand English to
understand the verbal instructions provided in the video. The subjects will be recruited
from flyers posted on bulletins boards on BYU’s campus, medical offices in Utah,
Oregon, and Montana, through participant or physician referrals, as well as via an email
sent to a community information mailing list for employees of Intel-Oregon.
Upon pre-entrance into the study, participants will be mailed a written letter of
informed consent detailing the possible benefits or negative consequences of the study.
The potential participants will also be contacted via phone and given the opportunity to
have any questions that they have relating to the study answered.
Participants must be older than 18, previously evaluated by a physician, and
diagnosed with fibromyalgia. Participants must not be pregnant or have cardiovascular
disease and must not be currently participating in any additional clinical trials. In order
to expedite verification of physician FMS diagnosis and approval for therapeutic
exercise, we will modify a piloted procedure initiated by Rooks et al (66) in which a form
will be mailed or faxed to each potential participant’s physician. Rooks et al received
92% of the forms within a two-week time frame (66).
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Instruments
There is currently no single measure used for evaluating change in fibromyalgia
research related studies. All of the instruments to be used in this study involve self-report
measures. However, patient questionnaires can be considered “as valuable as laboratory
or imaging data” in rheumatology care (20). All of these instruments have previously
been used in research studies involving FMS participants.
The Fibromyalgia Impact Questionnaire (FIQ) is a 2-page self-administered
instrument developed for evaluation of health status with regards to individuals who have
FMS (93). This is a 20-item instrument and is designed to measure physical function,
work status, depression, anxiety, sleep, pain, stiffness, fatigue, and general well being.
Items are measured on a Likert-type scale. Construct validity and test re-test reliability
have been established (93).
In order to measure change in participants’ perception of their ability to cope with
the pain and symptoms of FMS, the 8-item Stanford Arthritis Self Efficacy Scale (ASES)
will be used. This 1 page instrument has been developed to measure patients’ selfefficacy with regards to management of their rheumatic condition (94). This measure,
developed by Lorig et al, consists of 8 items and is self-administered. Reliability as well
as construct and concurrent validity have been established (94). The ASES has been
used previously to examine self-efficacy in FMS patients and the scale is modified
slightly in which the term “fibromyalgia” is exchanged for the term “arthritis” throughout
the scale.
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Pain and fatigue will be measured using visual analog scales (95, 96). We will
also use one item on the Stanford Chronic Disease Self-Efficacy scale to measure selfefficacy regarding ability to exercise (96).
Procedures
Upon signing the informed consent, demographic information will be collected
along with a brief medical history. Baseline measurements will also be collected and
recorded from results of the administration of the Fibromyalgia Impact Questionnaire
(FIQ), the Arthritis Self-Efficacy Scale (ASES) and pain and fatigue visual analog scales.
Each participant will also provide information as to his or her current regimen of
treatment. These data will include information regarding any drugs currently being
taken, therapeutic treatments, or exercise programs. Each participant will be asked to
continue his or her current treatment(s) as needed throughout the length of the study.
Participants will be randomly assigned to a “treatment” group or a treatment-asusual (TAU) control group. The treatment group will be provided with the exercise video
and accompanying exercise booklet. This group will be instructed to watch the video and
conduct the prescribed exercises at least 3 times per week and as much as twice a day.
Instructions for beginning the exercise program will be provided in the “Quick Start
Guide” that will be included with the video. The video consists of a combination of
therapeutic exercises and stretches along with verbal and visual instruction as to how to
perform each activity. Written instructions for the activities included in the video are
also provided in an accompanying booklet. Participants will be instructed to conduct the
exercises as directed in the “Quick Start Guide” or until they experience pain, fatigue, or
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have completed the 42-minute video. Each treatment participant will also be given a
logbook in which they will be instructed to record the frequency and duration of their
daily exercise sessions as well as any other treatments such as medication or other
therapies.
The treatment-as-usual (TAU) control group will be instructed to follow their
standard treatment for FMS symptoms. Both groups will record their treatments, such as
medications, therapy, and exercise. The control group will not receive the exercise video
or descriptions until after the completion of the study. To encourage documentation of
their treatments, all participants will be contacted halfway through the study via email,
phone, or United States Postal Service mail to remind them to record their weekly
treatment routines.
The items in the Fibromyalgia Impact Questionnaire (FIQ), the Arthritis SelfEfficacy Scale (ASES) and the VAS pain and fatigue scales will be measured at baseline
and at the conclusion of the four-week study. Results will be recorded and statistically
analyzed. After the completion of the study, the control group will have the opportunity
to receive a free copy of the video and book that the treatment group received.
Design and Statistical Analyses
This study will use a randomized groups pre-test post-test design in which the
exercise treatment group will be compared to the ‘treatment-as-usual’ control group. The
outcome measures of the Fibromyalgia Impact Questionnaire, the Arthritis Self-Efficacy
Scale, and pain and fatigue will be measured at baseline and at the end of week 4 in the
study. The data will be analyzed using a random coefficient growth curve model by
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means of SAS. The independent variables are the treatment groups and time. The
primary dependent variables are the FIQ score for overall disease impact, self-efficacy as
measured by the modified ASES, as well as pain and fatigue measured by the Visual
Analog Scales. Compliance will be determined as having conducted the exercises at least
three times per week for 4-week time frame.
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